US FDA’s Califf Says Publishing Complete Response Letters Could Help Fight Misinformation
But the commissioner also said proponents of releasing CRs may be making too much of the idea, because there are few CRs actually issued.
You may also be interested in...
A Level Playing Field? Medicare Tries To Balance Transparency, Confidentiality With Drug Price Negotiations
Drug manufacturers may want more ability to communicate about their drug price negotiation experience with Medicare than CMS is proposing, but if that jeopardizes protections for proprietary information, it may not be worthwhile.
A Little Help From His Friends: Califf Requests Patients Help US FDA Fight Misinformation
The idea seems to stem from thinking that human interaction is the best way to combat rumors and false statements.
US FDA Commissioner Califf Takes On Misinformation, Starting With ‘Rumor Control’
Agency leader expects to spend about a year developing a strategy to combat misinformation. On 5 August, the agency unveiled what appears to be an early component of the initiative – a web page titled Rumor Control, with facts about the safety and components of COVID-19 vaccines.